Pages that link to "Q35533985"
Jump to navigation
Jump to search
The following pages link to Induced sputum examination: diagnosis of pulmonary involvement in Fabry's disease (Q35533985):
Displaying 13 items.
- Fabry disease, respiratory symptoms, and airway limitation - a systematic review (Q26777930) (← links)
- Genetic influences and neonatal lung disease (Q35095596) (← links)
- Fabry disease: guidelines for the evaluation and management of multi-organ system involvement (Q36596408) (← links)
- Biochemical basis of Fabry disease with emphasis on mitochondrial function and protein trafficking (Q37641276) (← links)
- Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations (Q38027228) (← links)
- Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study. (Q40109069) (← links)
- Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage (Q46307739) (← links)
- Natural history of the respiratory involvement in Anderson-Fabry disease. (Q51747000) (← links)
- Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patients. (Q53214046) (← links)
- Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy. (Q53827424) (← links)
- Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases (Q61816865) (← links)
- Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease (Q79830152) (← links)
- Fabry disease during the COVID-19 pandemic. Why and how treatment should be continued (Q96608219) (← links)